| GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline |
Globe Newswire |
05/14 |
08:35 |
| 20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026 |
Globe Newswire |
05/14 |
08:31 |
| Live Ventures Reports Fiscal Second Quarter 2026 Financial Results |
Globe Newswire |
05/14 |
08:30 |
| Cycurion Reports First Quarter 2026 Results |
Globe Newswire |
05/14 |
08:30 |
| MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution |
Globe Newswire |
05/14 |
08:30 |
| HYCU® Wakes up Backup with aiR™; Launch Adds New AI Capabilities Across Protected Systems of Record Within Its Market-leading R-Cloud Resilience Platform |
Globe Newswire |
05/14 |
08:30 |
| GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors |
Globe Newswire |
05/14 |
08:30 |
| SPARC AI Inc. (OTC: SPAIF) Leading Out in Filling Gap, Developing Software-Only Drone System |
Globe Newswire |
05/14 |
08:30 |
| FDA Approves New Dosing Option for CRYSVITA® (burosumab-twza) in Adults With XLH |
Globe Newswire |
05/14 |
08:30 |
| Splash Beverage Group Announces Leadership Transition and Strategic Evolution Toward High-Growth Wellness & Cannabinoid Markets |
Globe Newswire |
05/14 |
08:30 |
| Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label |
Globe Newswire |
05/14 |
08:30 |
| Oncotelic Therapeutics Inc. (OTCQB: OTLC) Responds to BBB Challenge with Next-Gen Drug-Delivery Platform |
Globe Newswire |
05/14 |
08:30 |
| Fusemachines Research Shows How Agentic AI Is Becoming Core to Enterprise Hiring |
Globe Newswire |
05/14 |
08:30 |
| Biodexa issues letter to Shareholders |
Globe Newswire |
05/14 |
08:30 |
| Alarum to Release First Quarter 2026 Results and Host Conference Call on Thursday, May 28, 2026 |
Globe Newswire |
05/14 |
08:30 |
| Jackery Brings the Power and Savings to Memorial Day Weekend |
Globe Newswire |
05/14 |
08:30 |
| Dogwood Therapeutics Announces First Quarter 2026 Financial Results |
Globe Newswire |
05/14 |
08:30 |
| Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans |
Globe Newswire |
05/14 |
08:30 |
| Snail Games USA Explores Partnerships in One of Gaming’s Largest Markets with Gamescom LATAM Attendance |
Globe Newswire |
05/14 |
08:30 |
| SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Developing Distinct Next-Gen GLP-1 Built Around Novel Peptide |
Globe Newswire |
05/14 |
08:30 |
| Onfolio to Target $5-10 Million in EBITDA Acquisitions as AI Creates New Buying Opportunities |
Globe Newswire |
05/14 |
08:30 |
| CapeHaven Completes First Close of Funding and Initiates Operations to Encourage Yale’s Biotech Spinouts |
Globe Newswire |
05/14 |
08:30 |
| C3is Inc. announces the date for the release of the first quarter 2026 financial and operating results |
Globe Newswire |
05/14 |
08:30 |
| The Other Side of the Nuclear Renaissance: How Domestic Uranium Lands on the Pre-Feasibility Calendar |
Globe Newswire |
05/14 |
08:28 |
| The Quiet Consolidation of a Defense AI Platform |
Globe Newswire |
05/14 |
08:25 |
